Hampus Jacob Hillerstrom
Fondateur chez Proclara Biosciences, Inc.
Profil
Mr. Hampus J.
Hillerstrom is a President & Chief Executive Officer at LuMind IDSC Foundation and a Chief Financial Officer & Executive Vice President at Proclara Biosciences, Inc. Mr. Hillerstrom was previously employed as a President & Chief Executive Officer by LuMind Research Down Syndrome Foundation, an Associate by HealthCap Partners LLC, and a Partner by Venture Valuation VV AG.
He received his graduate degree from Massachusetts Institute of Technology, a graduate degree from Harvard Medical School, a graduate degree from St. Gallen University of Applied Sciences and an MBA from Harvard Business School.
Postes actifs de Hampus Jacob Hillerstrom
Sociétés | Poste | Début |
---|---|---|
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Fondateur | 01/12/2006 |
LuMind IDSC Foundation
LuMind IDSC Foundation Miscellaneous Commercial ServicesCommercial Services LuMind IDSC Foundation engages in accelerate research to increase availability of therapeutic, diagnostic, and medical care options and will empower families through education, connections, and support. The company was founded on March 21, 2019 and is headquartered in Burlington, MA. | Directeur Général | 21/03/2019 |
Anciens postes connus de Hampus Jacob Hillerstrom
Sociétés | Poste | Fin |
---|---|---|
Venture Valuation VV AG
Venture Valuation VV AG Investment ManagersFinance Venture Valuation VV AG is an independent research firm headquartered in Zurich, Switzerland. The firm was founded by Patrik Frei in 1999 and they provide independent assessment and valuation of companies, products and patents. Their focus is on technology companies in fast growing markets and industries including pharmaceuticals, Biotechnology, Medical Technology (Med Tech), nanotechnology, renewable energies (cleantech) and information technology (IT) / computer science / software. Venture Valuation’s clients include companies domiciled on almost all continents. The firm performs reviews both for investors as well as for companies themselves. | Corporate Officer/Principal | - |
LuMind Research Down Syndrome Foundation
LuMind Research Down Syndrome Foundation Miscellaneous Commercial ServicesCommercial Services LuMind Research Down Syndrome Foundation engages in biomedical research for the treatment of memory, learning and speech. The company was founded in 2004 and is headquartered in Burlington, MA. | Directeur Général | - |
HealthCap Partners LLC
HealthCap Partners LLC Investment ManagersFinance HealthCap Partners LLC (HealthCap Partners) is a private equity firm founded in 1996 by Kip Weatherwax and Jason K. Dodd. The firm is headquartered in Dallas, Texas. | Corporate Officer/Principal | - |
Formation de Hampus Jacob Hillerstrom
St. Gallen University of Applied Sciences | Graduate Degree |
Massachusetts Institute of Technology | Graduate Degree |
Harvard Business School | Masters Business Admin |
Harvard Medical School | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 5 |
---|---|
Proclara Biosciences, Inc.
Proclara Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Proclara Biosciences, Inc. provides treatment of chronic neurodegenerative diseases. The firm develops therapies for protein misfolding diseases, such as chronic diseases of aging and certain orphan indications by harnessing General Amyloid Interaction Motif (GAIM), which is a multi-target approach that reduces levels of pathological misfolded protein deposits. The company was founded by Hampus Jacob Hillerstrom and Jonathan Eithan Solomon in December 2006 and is headquartered in Cambridge, MA. | Health Technology |
HealthCap Partners LLC
HealthCap Partners LLC Investment ManagersFinance HealthCap Partners LLC (HealthCap Partners) is a private equity firm founded in 1996 by Kip Weatherwax and Jason K. Dodd. The firm is headquartered in Dallas, Texas. | Finance |
Venture Valuation VV AG
Venture Valuation VV AG Investment ManagersFinance Venture Valuation VV AG is an independent research firm headquartered in Zurich, Switzerland. The firm was founded by Patrik Frei in 1999 and they provide independent assessment and valuation of companies, products and patents. Their focus is on technology companies in fast growing markets and industries including pharmaceuticals, Biotechnology, Medical Technology (Med Tech), nanotechnology, renewable energies (cleantech) and information technology (IT) / computer science / software. Venture Valuation’s clients include companies domiciled on almost all continents. The firm performs reviews both for investors as well as for companies themselves. | Finance |
LuMind Research Down Syndrome Foundation
LuMind Research Down Syndrome Foundation Miscellaneous Commercial ServicesCommercial Services LuMind Research Down Syndrome Foundation engages in biomedical research for the treatment of memory, learning and speech. The company was founded in 2004 and is headquartered in Burlington, MA. | Commercial Services |
LuMind IDSC Foundation
LuMind IDSC Foundation Miscellaneous Commercial ServicesCommercial Services LuMind IDSC Foundation engages in accelerate research to increase availability of therapeutic, diagnostic, and medical care options and will empower families through education, connections, and support. The company was founded on March 21, 2019 and is headquartered in Burlington, MA. | Commercial Services |